aprepitant
chemical compound
Facts
17 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound[5]
- Has use
- medication[6]
- Active ingredient in
- Emend, Cinvanti
- Canonical SMILES
- CC(c1cc(cc(c1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)c4ccc(cc4)F[3]
- Chemical formula
- C₂₃H₂₁F₇N₄O₃[4]
- Defined daily dose
- 165 mg, 150 mg
- Has active ingredient
- Aprepitant
- Isomeric SMILES
- C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)NN3)c4ccc(cc4)F
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
- Mass
- 534.150188 Da
- Physically interacts with
- Tachykinin receptor 1[2]
- Pregnancy category
- Australian pregnancy category B1, US pregnancy category B
- Significant drug interaction
- rac-warfarin[7]
- Stereoisomer of
- 5-{[(2S,3R)-2-{(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one, 5-{[(2R,3R)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one, 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
- Subject has role
- antiemetic, NK1 receptor antagonists
- World Health Organisation international non-proprietary name
- aprepitant
🏷️ Also known as
en aprepitant
en 3-(((2R,3S)-3-(p-fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one
en 3-(((2R,3S)-3-(p-fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one
ar أبريبيتانت
fa اپرپیتانت
fi aprepitantti
fr aprépitant
ja アプレピタント
ko 에멘드
ko 아프레피탄트
pt Aprepitant
pt aprepitanto
uk апрепітант
zh 阿瑞匹坦
🔖 Identifiers · 38
- OpenAlex ID
- C2780574406
- ATC code
- A04AD12
- CAS Registry Number
- 170729-80-3
- ChEBI ID
- 499361
- ChEMBL ID
- CHEMBL1471
- ChemSpider ID
- 5293568
- DSSTOX compound identifier
- DTXCID801021794
- DSSTox substance ID
- DTXSID3049047
- DeCS ID
- 57711
- DrugBank ID
- DB00673
- DrugCentral ID
- 230
- EC number
- 677-636-6
Show all 38 identifiers +26
- ECHA Substance Infocard ID
- 100.202.762
- Electronic Essential Medicines List medicine ID
- 536
- Freebase ID
- /m/056ll1
- Guide to Pharmacology Ligand ID
- 3490
- Human Metabolome Database ID
- HMDB0014811
- InChIKey
- ATALOFNDEOCMKK-OITMNORJSA-N
- KEGG ID
- D02968
- LiverTox ID
- Aprepitant
- MeSH descriptor ID
- D000077608
- MeSH tree code
- D03.383.533.640.125
- MedlinePlus drug identifier
- a604003
- Microsoft Academic ID (discontinued)
- 2780574406
- NDF-RT ID
- N0000148809
- NSC number
- 748825
- National Drug Code
- 50370-0038, 55111-892, 51407-702, 68462-583, 65977-0024, 68001-667, 65372-1169, 51407-701, 51407-703, 0781-2321, 0781-2322, 0781-2323
- PDB ligand ID
- GBQ
- Probes And Drugs ID
- PD009855
- PubChem CID
- 135413536
- Reaxys registry number
- 8096869
- RxNorm CUI
- 358255
- SureChEMBL ID
- 264924
- UMLS CUI
- C1176306
- UNII
- 1NF15YR6UY
- UniChem compound ID
- 59034
- WikiProjectMed ID
- Aprepitant
🔗 Connections
← Significant drug interaction 3
Significant drug interaction 2
Subject has role 2
Has use 1
Subclass of 1
← Drug or therapy used for treatment 1
Press Enter · cited answer in seconds
0 sources
Summary
aprepitant is a type of chemical entity[1].